Anti-Atezolizumab ELISA Assay Kit
The Anti-Atezolizumab ELISA Assay Kit is For Research Use Only
Size: 12×8 wells
Sensitivity: cut-off
Incubation Time: 3.5 hours
Sample Type: Serum, Plasma
Sample Size: 25 µl
Alternative Name: Tecentriq
Assay Background
Atezolizumab (trade name Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). In 2015, it was in clinical trials as an immunotherapy for several types of solid tumors. It was under investigation by Genentech/Roche. In April 2016, Roche announced that atezolizumab had been granted fast track status for lung cancer by the FDA. In May 2018, Tecentriq was in combination with Avastin and standard chemotherapy for some patients with lung cancer was granted priority review. Anti-Drug Antibodies (ADA) may induce unwanted side effects in biopharmaceuticals. Hence, ADA has been subjected to increase in scrutiny by the regulatory authorities using immunogenicity safety studies. ADA has been observed in pre-clinical and clinical studies, resulting in significant changes in toxicology, pharmacokinetics and efficacy. These effects result from the generation of drug-induced (neutralizing) autoantibodies against Atezolizumab and can be responsible for allergic reaction, or even anaphylactic shock. This ELISA kit detects antibodies for Anti-Atezolizumab and may be used for monitoring immunogenicity.
Related Products
Atezolizumab ELISA Assay Kit
Anti-Daratumumab (Darzalex) ELISA Assay Kit
Anti-Rituximab ELISA Assay Kit